About James Dillon
Form D filings for BiVACOR in 2024 list James Dillon as chief executive officer and director.
Form D filings also name James Dillon as an executive officer and director at BioVentrix.
James Dillon first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name James Dillon in the role, so the role may have started earlier or lasted longer.
Bioventrix, Inc.
Executive officer and director
2021 – 2023 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
Key Colleagues at Startups
The people James Dillon works with at each company, as listed on that company's latest Form D.
BiVACOR Inc. · Form D, Aug 6, 2024
MM
Matt Mackey
Director
RK
Raymond Kelleher
Director
DT
Daniel Timms
Executive officer and director
BC
Bihua Chen
Director
RC
Raymond Cohen
Director
JJ
Jeannette Joughin
Director
PK
Paul Kelly
Director
Bioventrix, Inc. · Form D, Apr 4, 2023
RC
Raymond Cohen
Director
Steve Chartier
Executive officer
David Richmond
Co-Chief Executive Officer and director
AH
Andrew Hinson
Director
AC
Andrew Coats
Director
BC
Bihua Chen
Director
MT
Michael Taglich
Director
RW
Raphael Wisniewski
Director
RS
Rinda Sama
Director
OY
Ori Ben-Yehuda
Executive officer
WA
William Abbott
Chief Financial Officer
CW
Christopher Wolff
Executive officer